EpiStem Holdings Plc provided earnings guidance for the full year ended June 30, 2015. The company expected income over the full year was £4.5 million and EBITDA losses are expected to be £3.8 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 GBX | +10.45% | +1.37% | -77.23% |
05-24 | FTSE 100 stumbles as rain dampens retail sales | AN |
05-24 | Genedrive Wins Initial UK Orders for Hearing Loss Test for Infants | MT |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-77.23% | 6.65M | |
-24.07% | 17.02B | |
-42.47% | 2.84B | |
+13.40% | 1.8B | |
-10.21% | 1.5B | |
+32.69% | 1.33B | |
-21.01% | 911M | |
-25.79% | 849M | |
+5.15% | 824M | |
-27.85% | 604M |
- Stock Market
- Equities
- EHP Stock
- News genedrive plc
- EpiStem Holdings Plc Provides Earnings Guidance for the Full Year Ended June 30, 2015